Chronic opioid use can be reduced or discontinued after haematopoietic stem cell transplantation for sickle cell disease. Br J Haematol. 2020..
Improved health care utilization and costs in transplanted versus non-transplanted adults with sickle cell disease. PLoS One. 2020;15(2):e0229710..
Impact of high molecular risk mutations on transplant outcomes in patients with myelofibrosis. Biol Blood Marrow Transplant. 2019.
Synergistic Cytotoxic Effect of Busulfan and the PARP inhibitor Veliparib in Myeloproliferative Neoplasms. Biol Blood Marrow Transplant. 2019..
Persistent Fatigue in Hematopoietic Stem Cell Transplantation Survivors. Cancer Nurs. 2016..